{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:52:18Z","timestamp":1790679138130,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T14:08:41Z","timestamp":1316700521000},"page":"492-502","source":"Crossref","is-referenced-by-count":27,"title":["The antidepressant-like effects of the 3\u03b2-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels"],"prefix":"10.1016","volume":"62","author":[{"given":"Julie","family":"Espallergues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Mamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenao","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Temsamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Laruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.09.005_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0074-7742(01)46060-0","article-title":"Neurosteroid analysis","volume":"46","author":"Alomary","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-0327(98)00203-1","article-title":"Fluoxetine efficacy in menopausal women with and without estrogen replacement","volume":"55","author":"Amsterdam","year":"1999","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02211800","article-title":"Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome","volume":"12","author":"Baker","year":"1995","journal-title":"J.\u00a0Assist. Reprod. Genet."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib76","series-title":"Steroid Hormone Regulation of the Brain","first-page":"3","article-title":"Steroid hormones in the brain: several mechanisms?","author":"Baulieu","year":"1981"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0149-7634(05)80041-7","article-title":"Anticonvulsant steroids and the GABA\/benzodiazepine receptor-chloride ionophore complex","volume":"14","author":"Belelli","year":"1990","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjp.0704294","article-title":"Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands","volume":"134","author":"Bermack","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0031-9384(89)90238-2","article-title":"Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression","volume":"45","author":"Bernardi","year":"1989","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0006-3223(99)00156-0","article-title":"Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques","volume":"47","author":"Bethea","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(93)90260-Z","article-title":"Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function","volume":"45","author":"Bitran","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0006-3223(99)00066-9","article-title":"Dehydroepiandrosterone treatment of midlife dysthymia","volume":"45","author":"Bloch","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000441-199206000-00003","article-title":"Dehydroepiandrosterone: antiglucocorticoid action in mice","volume":"303","author":"Browne","year":"1992","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib77","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1073\/pnas.78.8.4704","article-title":"Characterization and measurement of dehydroepiandrosterone sulfate in rat brain","volume":"78","author":"Corp\u00e9chot","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endo.133.3.8365352","article-title":"Neurosteroids: 3\u03b1-hydroxy-5\u03b1-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats","volume":"133","author":"Corp\u00e9chot","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-8993(86)91500-3","article-title":"Anxiolytic activity of an endogenous adrenal steroid","volume":"398","author":"Crawley","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib13","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/bmj.290.6482.1617","article-title":"Progesterone and the premenstrual syndrome: a double blind crossover trial","volume":"290","author":"Dennerstein","year":"1980","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib14","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5\u03b1-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000097879","article-title":"Neuroactive steroids in depression and anxiety disorders: clinical studies","volume":"84","author":"Eser","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.psyneuen.2008.11.003","article-title":"The 3\u03b2-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice","volume":"34","author":"Espallergues","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-010-2053-y","article-title":"The antidepressant-like effect of the 3\u03b2-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of \u03b2-type estrogen receptors","volume":"214","author":"Espallergues","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00213-003-1707-4","article-title":"Interaction between estrogens and antidepressants in the FST in rats","volume":"173","author":"Estrada-Camarena","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-008-1291-8","article-title":"Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test","volume":"201","author":"Estrada-Camarena","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1995.03530010065036","article-title":"Ineffectiveness of progesterone suppository treatment for premenstrual syndrome","volume":"274","author":"Freeman","year":"1995","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI","volume":"35","author":"George","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2010.03.022","article-title":"Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats","volume":"68","author":"George","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2007.05.006","article-title":"Neurosteroids in the context of stress: implications for depressive disorders","volume":"116","author":"Girdler","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib23","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00023210-200115100-00005","article-title":"Role of estrogen in the aetiology and treatment of mood disorders","volume":"15","author":"Halbreich","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0028-3908(02)00330-1","article-title":"Behavioural action of ethanol in Porsolt\u2019s forced swim test: modulation by 3\u03b1-hydroxy-5\u03b1-pregnan-20-one","volume":"43","author":"Hirani","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0024-3205(98)00255-0","article-title":"Tissue specific effects of estrogen on monoamino oxidase A and B in the rat","volume":"63","author":"Holschneider","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib26","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/endo-125-4-2083","article-title":"Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells","volume":"125","author":"Jung-Testas","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/hbeh.1996.0006","article-title":"Allopregnanolone (THP) mediates anesthetic effects of progesterone in rat brain","volume":"30","author":"Korneyev","year":"1996","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1748-1716.1987.tb08202.x","article-title":"The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat\u2019s cerebral cortex","volume":"131","author":"Landgren","year":"1987","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0169-328X(03)00049-4","article-title":"Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor","volume":"11","author":"Landry","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(95)00387-Z","article-title":"Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor","volume":"284","author":"Ma","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(97)01406-6","article-title":"Enhancement of spatial attention in nociceptin\/orphanin FQ receptor-knockout mice","volume":"783","author":"Mamiya","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0188-0128(99)00024-X","article-title":"Progesterone reduces immobility in rats forced to swim","volume":"30","author":"Mart\u00ednez-Mota","year":"1999","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0028-3908(99)00018-0","article-title":"Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss","volume":"38","author":"Matsumoto","year":"1999","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.09.005_bib36","first-page":"S125","article-title":"Antiglucocorticoid therapies in major depression: a review","volume":"22","author":"Murphy","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(97)00067-8","article-title":"Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice","volume":"324","author":"Noda","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib38","first-page":"721","article-title":"Estrogen in the treatment of depression: neuropharmacological mechanisms","volume":"18","author":"Oppenheim","year":"1983","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G","article-title":"Molecular and cellular mechanisms of antidepressant drugs","volume":"4","author":"Owens","year":"1996","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0039-128X(78)90010-7","article-title":"Trilostane, an orally active inhibitor of steroid biosynthesis","volume":"32","author":"Potts","year":"1978","journal-title":"Steroids"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib42","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","article-title":"Sigma (\u03c31) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test","volume":"9","author":"Reddy","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1820011","article-title":"Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids","volume":"182","author":"Robichaud","year":"2004","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2826.2005.01292.x","article-title":"Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats","volume":"17","author":"Robichaud","year":"2005","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00023210-200115030-00002","article-title":"Psychotic and mood disorders associated with the perimenopausal period. Epidemiology, aetiology and management","volume":"15","author":"Robinson","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0006-3223(97)00521-0","article-title":"Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers","volume":"44","author":"Rupprecht","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00019442-199700520-00002","article-title":"Estrogen replacement and response to fluoxetine in surgically menopausal women","volume":"5","author":"Schneider","year":"1997","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0091-3057(92)90211-W","article-title":"Behavioural concomitants of regional changes in the brain\u2019s biogenic amines after apomorphine and amphetamine","volume":"41","author":"Schwarting","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation-induced decrease in both the abundance of neuroactive steroids and GABAA receptor function in rat brain","volume":"75","author":"Serra","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib52","first-page":"319","article-title":"Augmentation of antidepressants by estrogen","volume":"34","author":"Stahl","year":"1998","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-3956(00)00006-6","article-title":"Fluoxetine decreases concentration of 3\u03b1,5\u03b1, tetra-hydrodeoxycorticosterone (THDOC) in major depression","volume":"34","author":"Str\u00f6hle","year":"2000","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3\u03b1 reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"8675","key":"10.1016\/j.neuropharm.2011.09.005_bib55","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(89)91940-5","article-title":"Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer\u2019s disease","volume":"2","author":"Svec","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib56","first-page":"1273","article-title":"Serum dehydroepiandrosterone sulfate levels as an individual marker","volume":"79","author":"Thomas","year":"1994","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10401239009150005","article-title":"24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and\/or pharmacotherapy","volume":"2","author":"Tollefson","year":"1990","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib58","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","article-title":"The antidepressant-like effect induced by \u03c31-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test","volume":"298","author":"Urani","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib59","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)02577-0","article-title":"Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression","volume":"976","author":"Uzunova","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-005-0201-6","article-title":"Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action","volume":"186","author":"Uzunova","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib61","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/abio.2000.4841","article-title":"Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography\/mass spectrometry","volume":"287","author":"Vall\u00e9e","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1257-1","article-title":"Neurosteroids in depression: a review","volume":"165","author":"Van Broekhoven","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01674829609025661","article-title":"Effect of progesterone and its 5\u03b1 and 5\u03b2 metabolites on symptoms of premenstrual syndrome according to route of administration","volume":"17","author":"Vanselow","year":"1996","journal-title":"J.\u00a0Psychosom. Obstet. Gynaecol."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jphs.10191FP","article-title":"Pharmacological interaction with the sigma1 (\u03c31) receptor in the acute behavioural effects of antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/abbi.1997.0230","article-title":"Regulation of CYP3A9 gene expression by estrogen and catalytic studies using P450 3A9 expressed in Escherichia coli","volume":"344","author":"Wang","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib67","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.7638596","article-title":"Depression in women: implications for health care research","volume":"269","author":"Weissman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib68","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double blind treatment of major depression with dihydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00006842-199909000-00011","article-title":"Treatment of depression with antiglucocorticoid drugs","volume":"61","author":"Wolkowitz","year":"1999","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib70","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0006-3223(98)00267-4","article-title":"Antiglucocorticoid treatment of depression: double-blind ketoconazole","volume":"45","author":"Wolkowitz","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-6632.1995.tb17403.x-i1","article-title":"Antidepressant and cognition-enhancing effects of DHEA in major depression","volume":"774","author":"Wolkowitz","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.09.005_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0039-128X(95)00220-K","article-title":"Neurosteroids in the mouse brain: behavioural and pharmacological effects of a 3\u03b2-hydroxysteroid dehydrogenase inhibitor","volume":"61","author":"Young","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.neuropharm.2011.09.005_bib74","first-page":"505","article-title":"Neurosteroids: pharmacological effects of a 3\u03b2-hydroxy-steroid dehydrogenase inhibitor","volume":"2","author":"Young","year":"1994","journal-title":"Endocrine"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:21:59Z","timestamp":1741724519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811003996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811003996"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.09.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}